Virtual reality could make depression therapy more immersive and effective

NCT ID NCT07703397

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests a new virtual reality (VR) software that delivers behavioral activation therapy for people with depression. Behavioral activation helps people re-engage in positive activities to improve mood. Participants use hand-tracking to interact with the VR environment, completing rewarding tasks. The trial compares the VR group to a waitlist control group to see if the VR program reduces depression symptoms and increases engagement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a virtual reality software program that delivers behavioral activation therapy using hand-tracking technology
What this could lead to
If effective, this VR approach could offer a new, engaging way to deliver behavioral activation therapy for depression, potentially making treatment more accessible and appealing.
What could go wrong
This is an early-stage study with only 50 participants, so results may not apply broadly. The VR software is new and may not outperform standard therapy or may cause side effects like motion sickness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BEHAVIORAL ACTIVATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aydin Adnan Menderes University, Department of Psychology

    Aydin, 09010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.